Stay updated on Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial page.

Latest updates to the Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial page
- CheckyesterdayChange DetectedDifference0.0%

- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedAdded Naples, Italy, 80131 as a study site and removed Napoli, Italy, 80131 to standardize location naming. Updated the Publications section with the Lancet Oncology 2019 extended follow-up citation and removed the related erratum entries.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange Detected- Revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check44 days agoChange DetectedThe Publications section now includes the extended follow-up Lancet Oncology article for CheckMate 214 and its erratum, replacing the previous 2019 Lancet Oncology citation.SummaryDifference0.0%

- Check51 days agoChange Detected- Minor platform version update from Revision: v3.4.1 to v3.4.2; no user-visible changes to study details or layout observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check59 days agoChange DetectedAdded a 2019 Lancet Oncology publication on patient-reported outcomes for CheckMate 214 and removed the Erratum reference for that publication.SummaryDifference0.0%

Stay in the know with updates to Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial page.